Ekso Financial Statements From 2010 to 2024

EKSO Stock  USD 0.69  0.03  4.17%   
Ekso Bionics financial statements provide useful quarterly and yearly information to potential Ekso Bionics Holdings investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Ekso Bionics financial statements helps investors assess Ekso Bionics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Ekso Bionics' valuation are summarized below:
Gross Profit
6.7 M
Profit Margin
(0.63)
Market Capitalization
15.2 M
Enterprise Value Revenue
0.7496
Revenue
17.7 M
We have found one hundred twenty available fundamental signals for Ekso Bionics Holdings, which can be analyzed and compared to other ratios and to its rivals. Self-guided Investors are advised to verify Ekso Bionics' prevailing fundamentals against the trend between 2010 and 2024 to make sure the company can sustain itself down the road. As of the 26th of November 2024, Market Cap is likely to drop to about 30.7 M. In addition to that, Enterprise Value is likely to drop to about 23.1 M

Ekso Bionics Total Revenue

12.33 Million

Check Ekso Bionics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ekso Bionics' main balance sheet or income statement drivers, such as Interest Expense of 271.3 K, Selling General Administrative of 8.7 M or Other Operating Expenses of 28.5 M, as well as many indicators such as Price To Sales Ratio of 1.8, Dividend Yield of 0.11 or PTB Ratio of 2.61. Ekso financial statements analysis is a perfect complement when working with Ekso Bionics Valuation or Volatility modules.
  
Check out the analysis of Ekso Bionics Correlation against competitors.

Ekso Bionics Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets26 M28.9 M22.2 M
Slightly volatile
Short and Long Term Debt TotalM7.2 M4.2 M
Slightly volatile
Other Current Liabilities2.3 M2.5 M1.8 M
Slightly volatile
Total Current Liabilities6.6 M8.1 M5.6 M
Slightly volatile
Total Stockholder Equity13.6 M12.6 M10.8 M
Slightly volatile
Cash16.1 M8.6 M13.8 M
Slightly volatile
Cash And Short Term Investments8.2 M8.6 M13.2 M
Slightly volatile
Common Stock Total Equity8.7 K9.2 K33.6 K
Very volatile
Liabilities And Stockholders Equity26 M28.9 M22.2 M
Slightly volatile
Non Current Liabilities Total7.4 M8.2 M5.9 M
Slightly volatile
Total Liabilities13.4 M16.3 M11.5 M
Slightly volatile
Total Current Assets22.1 M20.2 M18.9 M
Slightly volatile
Short Term Debt1.1 MM971.4 K
Slightly volatile
Common Stock14.2 K15 K35 K
Very volatile
Common Stock Shares Outstanding14.6 M13.9 M5.8 M
Slightly volatile
Other Stockholder Equity179.6 M251.6 M131.7 M
Slightly volatile
Other Liabilities1.2 M1.3 M4.4 M
Pretty Stable
Net Tangible Assets15.5 M22.8 M17.1 M
Pretty Stable
Property Plant And Equipment Net2.7 MM2.4 M
Slightly volatile
Current Deferred Revenue1.4 MM2.2 M
Slightly volatile
Accounts Payable2.5 M1.8 M1.9 M
Slightly volatile
Non Current Assets TotalM8.7 M4.5 M
Pretty Stable
Non Currrent Assets Other504.2 K392 KM
Slightly volatile
Other Assets140.2 K147.6 KM
Slightly volatile
Long Term Debt3.8 M4.8 M2.6 M
Slightly volatile
Net Receivables3.9 M5.6 MM
Slightly volatile
Long Term Debt Total11 M10.5 M4.9 M
Slightly volatile
Capital Surpluse165 M235 M149.1 M
Slightly volatile
Inventory2.9 MM2.1 M
Slightly volatile
Other Current Assets651.2 K875 K541.5 K
Slightly volatile
Deferred Long Term Liabilities30.8 K32.4 K1.6 M
Slightly volatile
Property Plant And Equipment Gross6.5 M6.2 M2.8 M
Slightly volatile
Short and Long Term Debt2.4 M1.2 M1.6 M
Slightly volatile
Intangible Assets5.1 M4.9 M2.6 M
Slightly volatile
Property Plant Equipment2.6 M4.6 M2.4 M
Slightly volatile
Non Current Liabilities Other99.8 K105 K599.5 K
Slightly volatile
Deferred Long Term Asset ChargesM2.3 M2.5 M
Slightly volatile
Capital Lease Obligations659.6 K1.1 M385.4 K
Slightly volatile
Net Invested Capital22.4 M18.7 M24.2 M
Pretty Stable
Net Working Capital20.4 M12.1 M22 M
Slightly volatile
Capital Stock26.5 K15 K48.6 K
Slightly volatile

Ekso Bionics Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative8.7 M10.7 M6.9 M
Slightly volatile
Other Operating Expenses28.5 M33.4 M22.6 M
Slightly volatile
Total Operating Expenses22.4 M24.2 M17.8 M
Slightly volatile
Selling And Marketing Expenses7.7 M8.5 M8.8 M
Pretty Stable
Total Revenue12.3 M18.3 M9.7 M
Slightly volatile
Gross Profit5.1 M9.1 M3.8 M
Slightly volatile
Research Development4.2 MM4.8 M
Very volatile
Cost Of Revenue7.3 M9.2 M5.9 M
Slightly volatile
Non Recurring482 K389.7 K553.9 K
Slightly volatile
Reconciled Depreciation832.7 K1.3 M1.3 M
Slightly volatile

Ekso Bionics Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow16.7 M20.5 M13.3 M
Slightly volatile
Total Cash From Financing Activities330.6 K348 K12.8 M
Very volatile
End Period Cash Flow8.2 M8.6 M13.2 M
Slightly volatile
Stock Based Compensation2.7 M2.2 M2.1 M
Slightly volatile
Depreciation898.9 K1.7 MM
Pretty Stable
Dividends Paid8.3 M9.3 M10.1 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.81.896653.688
Slightly volatile
Dividend Yield0.110.130.1403
Slightly volatile
PTB Ratio2.612.7501358.4 K
Slightly volatile
Days Sales Outstanding89.1113103
Slightly volatile
Book Value Per Share0.860.90915.2102
Slightly volatile
Average Payables1.3 M1.5 M1.6 M
Slightly volatile
Stock Based Compensation To Revenue0.120.12230.22
Pretty Stable
Capex To Depreciation0.08780.09250.8811
Slightly volatile
PB Ratio2.612.7501358.4 K
Slightly volatile
Inventory Turnover1.731.82183.5509
Slightly volatile
Days Of Inventory On Hand115200133
Slightly volatile
Payables Turnover5.234.98112.9059
Slightly volatile
Sales General And Administrative To Revenue0.990.5850.9895
Slightly volatile
Average Inventory536.1 K603.2 K656.8 K
Slightly volatile
Research And Ddevelopement To Revenue0.260.27490.7992
Slightly volatile
Capex To Revenue0.00820.00860.1177
Slightly volatile
Cash Per Share0.590.62297.0316
Slightly volatile
Days Payables Outstanding69.6173.2777148
Slightly volatile
Income Quality0.740.79310.8806
Very volatile
Intangibles To Total Assets0.190.18410.0626
Slightly volatile
Net Debt To EBITDA0.110.11140.701
Pretty Stable
Current Ratio2.532.48963.0646
Slightly volatile
Tangible Book Value Per Share0.50.52524.9384
Slightly volatile
Receivables Turnover4.113.23814.0468
Slightly volatile
Graham Number4.54.734731.235
Slightly volatile
Shareholders Equity Per Share0.860.90915.2102
Slightly volatile
Debt To Equity0.490.5113983
Slightly volatile
Capex Per Share0.01080.01130.6714
Slightly volatile
Revenue Per Share1.251.31823.8525
Slightly volatile
Interest Debt Per Share0.460.48661.2744
Pretty Stable
Debt To Assets0.210.222941.8976
Slightly volatile
Operating Cycle196313227
Slightly volatile
Price Book Value Ratio2.612.7501358.4 K
Slightly volatile
Days Of Payables Outstanding69.6173.2777148
Slightly volatile
Ebt Per Ebit1.141.00571.1737
Slightly volatile
Company Equity Multiplier2.182.2945.668
Slightly volatile
Long Term Debt To Capitalization0.420.27710.4052
Slightly volatile
Total Debt To Capitalization0.440.33830.4147
Slightly volatile
Debt Equity Ratio0.490.5113983
Slightly volatile
Net Income Per E B T1.071.110.9815
Slightly volatile
Cash Ratio1.921.06422.3718
Very volatile
Days Of Inventory Outstanding115200133
Slightly volatile
Days Of Sales Outstanding89.1113103
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.131.0131.0541
Slightly volatile
Price To Book Ratio2.612.7501358.4 K
Slightly volatile
Fixed Asset Turnover3.466.10323.973
Slightly volatile
Debt Ratio0.210.222941.8976
Slightly volatile
Price Sales Ratio1.81.896653.688
Slightly volatile
Asset Turnover0.60.632150.6021
Slightly volatile
Gross Profit Margin0.280.49670.3304
Slightly volatile
Price Fair Value2.612.7501358.4 K
Slightly volatile

Ekso Bionics Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap30.7 M32.4 M181 M
Slightly volatile
Enterprise Value23.1 M24.3 M171.9 M
Slightly volatile

Ekso Fundamental Market Drivers

Cash And Short Term Investments8.6 M

Ekso Upcoming Events

26th of March 2024
Upcoming Quarterly Report
View
25th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
26th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Ekso Bionics Financial Statements

Ekso Bionics investors utilize fundamental indicators, such as revenue or net income, to predict how Ekso Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred RevenueM1.4 M
Total Revenue18.3 M12.3 M
Cost Of Revenue9.2 M7.3 M
Stock Based Compensation To Revenue 0.12  0.12 
Sales General And Administrative To Revenue 0.59  0.99 
Research And Ddevelopement To Revenue 0.27  0.26 
Capex To Revenue 0.01  0.01 
Revenue Per Share 1.32  1.25 
Ebit Per Revenue(0.83)(0.87)

Pair Trading with Ekso Bionics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ekso Bionics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ekso Bionics will appreciate offsetting losses from the drop in the long position's value.

Moving against Ekso Stock

  0.76DOCS Doximity Buyout TrendPairCorr
  0.74FOXO FOXO TechnologiesPairCorr
  0.71ITGR Integer Holdings CorpPairCorr
  0.69VMD Viemed HealthcarePairCorr
  0.34ENOV Enovis CorpPairCorr
The ability to find closely correlated positions to Ekso Bionics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ekso Bionics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ekso Bionics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ekso Bionics Holdings to buy it.
The correlation of Ekso Bionics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ekso Bionics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ekso Bionics Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ekso Bionics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Ekso Bionics Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ekso Bionics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ekso Bionics Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ekso Bionics Holdings Stock:
Check out the analysis of Ekso Bionics Correlation against competitors.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ekso Bionics. If investors know Ekso will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ekso Bionics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.64)
Revenue Per Share
1.004
Quarterly Revenue Growth
(0.10)
Return On Assets
(0.24)
Return On Equity
(0.74)
The market value of Ekso Bionics Holdings is measured differently than its book value, which is the value of Ekso that is recorded on the company's balance sheet. Investors also form their own opinion of Ekso Bionics' value that differs from its market value or its book value, called intrinsic value, which is Ekso Bionics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ekso Bionics' market value can be influenced by many factors that don't directly affect Ekso Bionics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ekso Bionics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ekso Bionics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ekso Bionics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.